Systematic review with meta‐analysis: liver manifestations and outcomes in COVID‐19

2020254 citationsReviewbronze Open Access

Authors

Anand V. Kulkarni · Asian Institute of Gastroenterology

Pramod Kumar · Asian Institute of Gastroenterology

Harsh Vardhan Tevethia · Asian Institute of Gastroenterology

Madhumita Premkumar · Post Graduate Institute of Medical Education and Research

Juan Pablo Arab · Pontificia Universidad Católica de Chile

Roberto Cândia · Pontificia Universidad Católica de Chile

Rupjyoti Talukdar

Abstract

Elevated liver chemistries are common at presentation and during COVID-19. The severity of elevated liver chemistries correlates with the outcome of COVID-19. The presence of CLD does not alter the outcome of COVID-19. Further studies are needed to analyse the outcomes of compensated and decompensated liver disease.

Topics & Keywords

COVID-19 Clinical Research Studies Liver Disease Diagnosis and Treatment Long-Term Effects of COVID-19

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Alimentary Pharmacology & Therapeutics

Volume 52, Issue 4, pp. 584-599

DOI: 10.1111/apt.15916

Field-Weighted Citation Impact: 5.62